Insider Selling: CryoPort Inc (NASDAQ:CYRX) Director Sells 5,000 Shares of Stock

CryoPort Inc (NASDAQ:CYRX) Director Richard J. Berman sold 5,000 shares of the firm’s stock in a transaction dated Tuesday, November 19th. The shares were sold at an average price of $14.66, for a total value of $73,300.00.

CryoPort stock traded down $0.28 during mid-day trading on Friday, hitting $14.66. The stock had a trading volume of 398,168 shares, compared to its average volume of 382,534. The company has a current ratio of 17.91, a quick ratio of 17.84 and a debt-to-equity ratio of 0.17. CryoPort Inc has a 12 month low of $8.28 and a 12 month high of $25.02. The stock has a market capitalization of $534.79 million, a PE ratio of -47.29 and a beta of 0.77. The stock has a 50-day simple moving average of $14.59 and a two-hundred day simple moving average of $17.90.

CryoPort (NASDAQ:CYRX) last issued its earnings results on Thursday, November 7th. The consumer goods maker reported ($0.05) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.07) by $0.02. CryoPort had a negative return on equity of 26.50% and a negative net margin of 64.63%. The firm had revenue of $9.58 million for the quarter, compared to analysts’ expectations of $9.49 million. During the same quarter last year, the business earned ($0.07) earnings per share. The company’s revenue was up 81.1% compared to the same quarter last year. Sell-side analysts expect that CryoPort Inc will post -0.58 earnings per share for the current fiscal year.

Several equities analysts recently issued reports on CYRX shares. BidaskClub cut CryoPort from a “sell” rating to a “strong sell” rating in a report on Saturday, October 5th. ValuEngine upgraded CryoPort from a “hold” rating to a “buy” rating in a report on Friday, November 1st. One investment analyst has rated the stock with a sell rating and five have assigned a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $24.00.

Institutional investors and hedge funds have recently modified their holdings of the business. Handelsbanken Fonder AB acquired a new stake in shares of CryoPort during the second quarter worth about $2,933,000. Taylor Wealth Management Partners raised its position in shares of CryoPort by 0.7% during the second quarter. Taylor Wealth Management Partners now owns 299,830 shares of the consumer goods maker’s stock worth $5,493,000 after purchasing an additional 2,050 shares during the period. Taylor Frigon Capital Management LLC raised its position in shares of CryoPort by 2.5% during the second quarter. Taylor Frigon Capital Management LLC now owns 204,799 shares of the consumer goods maker’s stock worth $3,751,000 after purchasing an additional 4,954 shares during the period. SG Americas Securities LLC acquired a new stake in shares of CryoPort during the second quarter worth about $249,000. Finally, Wells Fargo & Company MN raised its position in shares of CryoPort by 13.3% during the second quarter. Wells Fargo & Company MN now owns 62,055 shares of the consumer goods maker’s stock worth $1,136,000 after purchasing an additional 7,291 shares during the period. Hedge funds and other institutional investors own 68.10% of the company’s stock.

CryoPort Company Profile

CryoPort, Inc engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers.

Featured Article: Why do companies issue convertible shares?

Receive News & Ratings for CryoPort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort and related companies with MarketBeat.com's FREE daily email newsletter.